Dr. Dalia Rotstein is an attending staff neurologist at St. Michael’s Hospital, where she specializes in multiple sclerosis (MS). She is also an Assistant Professor in the Department of Medicine, Division of Neurology at the University of Toronto. Her research is focused on the epidemiology of MS, disease modifying therapy, and dietary and nutritional influences on MS. Recent work includes studies of incidence and prevalence patterns of MS in Ontario, interactions between vitamin D supplementation and disease modifying therapy, and the relationship between BMI and MS disease course. Dr. Rotstein is also investigating No Evidence of Disease Activity (NEDA), a new outcome measure in MS akin to disease free status, which has become a treatment goal with the expanding array of highly effective MS therapies.
Dr. Rotstein enjoys mentoring residents and grad students interested in MS clinical care and research. In addition, she is actively involved in international neurology education. In 2009, she founded the Neurology International Residents’ Videoconferencing Exchange (NIRVE) and now serves as the faculty mentor for this program. This monthly educational videoconference connects residents at sites in Toronto, France, Russia, and Brazil to learn about common neurologic diseases.